BIZ NEWS: Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise - BUSINESS DAILY

Hot

Post Top Ad

Your Ad Spot

Monday, 6 July 2020

BIZ NEWS: Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise


Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise



Regeneron said it began late-stage clinical trials to assess the effectiveness of its antibody cocktail.

via FOX BUSINESS NEWS https://ift.tt/2ZEm5cs

No comments:

Post a Comment

Post Top Ad